B. Ogilvie

发表

A. Parkinson, Greg J. Loewen, B. Ogilvie, 2010 .

:Four Centuries of the Word Geology: Ulisse Aldrovandi 1603 in Bologna

B. Ogilvie, 2006 .

An Assessment of the In Vitro Inhibition of Cytochrome P450 Enzymes, UDP-Glucuronosyltransferases, and Transporters by Phosphodiester- or Phosphorothioate-Linked Oligonucleotides

A. Parkinson, B. Ogilvie, F. Kazmi, 2018, Drug Metabolism and Disposition.

The Proton Pump Inhibitor, Omeprazole, but Not Lansoprazole or Pantoprazole, Is a Metabolism-Dependent Inhibitor of CYP2C19: Implications for Coadministration with Clopidogrel

A. Rostami-Hodjegan, A. Parkinson, B. Ogilvie, 2011, Drug Metabolism and Disposition.

An evaluation of the dilution method for identifying metabolism-dependent inhibitors (MDIs) of cytochrome P450 (CYP) enzymes

A. Parkinson, B. Ogilvie, Brandy L. Paris, 2011 .

Accelerated Communication GLUCURONIDATION CONVERTS GEMFIBROZIL TO A POTENT , METABOLISM-DEPENDENT INHIBITOR OF CYP 2 C 8 : IMPLICATIONS FOR DRUG-DRUG INTERACTIONS

A. D. Rodrigues, A. Parkinson, Donglu Zhang, 2005 .

An Evaluation of the Dilution Method for Identifying Metabolism-Dependent Inhibitors of Cytochrome P450 Enzymes

A. Parkinson, B. Ogilvie, Brandy L. Paris, 2011, Drug Metabolism and Disposition.

Drugs as victims and perpetrators and the pharmacokinetic concept of maximum exposure

Brian W. Ogilvie, Andrew Parkinson, A. Parkinson, 2014 .

Clinical assessment of drug–drug interactions of tasimelteon, a novel dual melatonin receptor agonist

B. Ogilvie, W. Kramer, R. Torres, 2015, Journal of clinical pharmacology.

Construction of Triple-Transfected Cells [Organic Anion-Transporting Polypeptide (OATP) 1B1/Multidrug Resistance-Associated Protein (MRP) 2/MRP3 and OATP1B1/MRP2/MRP4] for Analysis of the Sinusoidal Function of MRP3 and MRP4

H. Kusuhara, Y. Sugiyama, A. Parkinson, 2009, Drug Metabolism and Disposition.

Evaluation of Ketoconazole and Its Alternative Clinical CYP3A4/5 Inhibitors as Inhibitors of Drug Transporters: The In Vitro Effects of Ketoconazole, Ritonavir, Clarithromycin, and Itraconazole on 13 Clinically-Relevant Drug Transporters

Lydia M. M. Vermeer, B. Ogilvie, David B. Buckley, 2016, Drug Metabolism and Disposition.

On the Mechanism of Hepatocarcinogenesis of Benzodiazepines: Evidence that Diazepam and Oxazepam are CYP2B Inducers in Rats, and both CYP2B and CYP4A Inducers in Mice

A. Parkinson, B. Ogilvie, Neda Leonard, 2006, Drug metabolism reviews.

Distribution, metabolism, and excretion of the anti-angiogenic compound SU5416.

Weiwei Tan, Qingling Zhang, S. Wong, 2006, Toxicology in vitro : an international journal published in association with BIBRA.

In vitro evaluation suggests fenfluramine and norfenfluramine are unlikely to act as perpetrators of drug interactions

Brooks M. Boyd, B. Ogilvie, M. Czerwiński, 2022, Pharmacology research & perspectives.

System-dependent outcomes during the evaluation of drug candidates as inhibitors of cytochrome P450 (CYP) and uridine diphosphate glucuronosyltransferase (UGT) enzymes: human hepatocytes versus liver microsomes versus recombinant enzymes.

A. Parkinson, B. Ogilvie, Brandy L. Paris, 2010, Drug metabolism and pharmacokinetics.

:Commerce with the Classics: Ancient Books and Renaissance Readers

B. Ogilvie, 2000 .

The Many Books of Nature: Renaissance Naturalists and Information Overload

B. Ogilvie, Brian W Ogilvie, 2003, Journal of the history of ideas.

Commonplace Learning: Ramism and its German Ramifications, 1543–1630. By Howard Hotson. Oxford: Oxford University Press. 2007. Pp. xvi + 333. Cloth $199.00. ISBN 978-0-19-817430-1.

B. Ogilvie, 2012, Central European History.

The Science of Describing: Natural History in Renaissance Europe

B. Ogilvie, 2006 .

A Science of Describing

Brian W. Ogilvie, B. Ogilvie, 2006 .

Use of enzyme inhibitors to evaluate the conversion pathways of ester and amide prodrugs: a case study example with the prodrug ceftobiprole medocaril.

Mark D. Johnson, A. Schmitt-Hoffmann, A. Parkinson, 2012, Journal of pharmaceutical sciences.

In vitro evaluation of fenfluramine and norfenfluramine as victims of drug interactions

Brooks M. Boyd, S. Muranjan, B. Ogilvie, 2022, Pharmacology research & perspectives.

AN IN VITRO INVESTIGATION INTO THE MECHANISM OF THE CLINICALLY RELEVANT DRUG-DRUG INTERACTION BETWEEN OMEPRAZOLE OR ESOMEPRAZOLE AND CLOPIDOGREL

B. Ogilvie, 2015 .

Effects of monocyte chemoattractant protein‐1, macrophage inflammatory protein‐1α, and interferon‐α2a on P450 enzymes in human hepatocytes in vitro

B. Ogilvie, M. Czerwiński, Krystal Gilligan, 2019, Pharmacology research & perspectives.

Biotransformation of the anti-angiogenic compound SU5416.

G. Wagner, M. Shet, A. Parkinson, 2000, Drug metabolism and disposition: the biological fate of chemicals.

Attending to insects: Francis Willughby and John Ray

B. Ogilvie, 2012, Notes and Records of the Royal Society.

GLUCURONIDATION CONVERTS GEMFIBROZIL TO A POTENT, METABOLISM-DEPENDENT INHIBITOR OF CYP2C8: IMPLICATIONS FOR DRUG-DRUG INTERACTIONS

A. D. Rodrigues, A. Parkinson, Donglu Zhang, 2006, Drug Metabolism and Disposition.

In Vitro Inhibition and Induction of Human Liver Cytochrome P450 Enzymes by Milnacipran

A. Parkinson, B. Ogilvie, Brandy L. Paris, 2009, Drug Metabolism and Disposition.

In Vitro Approaches for Studying the Inhibition of Drug-Metabolizing Enzymes and Identifying the Drug-Metabolizing Enzymes Responsible for the Metabolism of Drugs (Reaction Phenotyping) with Emphasis on Cytochrome P450

A. Parkinson, B. Ogilvie, P. Yerino, 2019, Drug-Drug Interactions.

Visions of ancient natural history

B. Ogilvie, 2018, Worlds of Natural History.

Scientific Archives in the Age of Digitization

Brian Ogilvie, B. Ogilvie, 2016, Isis.

The in vitro evaluation of ketoconazole and its alternative clinical CYP3A4/5 inhibitors (ritonavir, clarithromycin and itraconazole) as inhibitors of non-CYP enzymes

B. Ogilvie, P. Yerino, David B. Buckley, 2017 .

Prediction of the Overall Renal Tubular Secretion and Hepatic Clearance of Anionic Drugs and a Renal Drug-Drug Interaction Involving Organic Anion Transporter 3 in Humans by In Vitro Uptake Experiments

K. Maeda, H. Kusuhara, Y. Sugiyama, 2011, Drug Metabolism and Disposition.

Image and Text in Natural History, 1500–1700

B. Ogilvie, 2003 .

Nature ’ s Bible : Insects in Seventeenth-Century European Art and Science

B. Ogilvie, 2015 .

The Many Books of Nature: Renaissance Naturalists and Information Overload

B. Ogilvie, 2003, Journal of the history of ideas.

An in Vitro Evaluation of the Victim and Perpetrator Potential of the Anticancer Agent Laromustine (VNP40101M), Based on Reaction Phenotyping and Inhibition and Induction of Cytochrome P450 Enzymes

A. Nassar, A. Parkinson, B. Ogilvie, 2009, Drug Metabolism and Disposition.

Order of Insects

B. Ogilvie, 2014 .

H. Kusuhara, Y. Sugiyama, A. Parkinson, 2009, Drug Metabolism and Disposition.

The Reliability of Estimating Ki Values for Direct, Reversible Inhibition of Cytochrome P450 Enzymes from Corresponding IC50 Values: A Retrospective Analysis of 343 Experiments

A. Parkinson, B. Ogilvie, Brandy L. Paris, 2015, Drug Metabolism and Disposition.

The Reliability of Estimating K i Values for Direct , Reversible Inhibition of Cytochrome P 450 Enzymes from Corresponding IC 50 Values : A Retrospective Analysis of 343 Experiments s

A. Parkinson, B. Ogilvie, Brandy L. Paris, 2015 .

DMD066597 1744..1750

A. Parkinson, B. Ogilvie, Brandy L. Paris, 2015 .

Identification of a novel carbamoyl glucuronide as a metabolism-dependent inhibitor of CYP 2 C 8

A. Parkinson, B. Ogilvie, Brian D. Smith, 2010 .